imipramine has been researched along with lysophosphatidylcholines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cesura, AM; Müller, K; Peyer, M; Pletscher, A | 1 |
| Bauer, J; Bock, J; Hofmann, C; Huy, C; Liebisch, G; Obermeier, F; Schmitz, G | 1 |
| Ishikawa, M; Maekawa, K; Murayama, M; Nakatsu, N; Saito, K; Saito, Y; Senoo, Y; Urata, M; Yamada, H | 1 |
3 other study(ies) available for imipramine and lysophosphatidylcholines
| Article | Year |
|---|---|
Solubilization of imipramine-binding protein from human blood platelets.
Topics: Blood Platelets; Carrier Proteins; Cholic Acids; Detergents; Digitonin; Humans; Imipramine; Lysophosphatidylcholines; Membrane Proteins; Molecular Weight; Solubility | 1983 |
Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.
Topics: Animals; Caco-2 Cells; Ceramides; Colitis; Gene Expression Regulation, Enzymologic; Humans; Imipramine; Interleukin-1beta; L-Selectin; Lipid Metabolism; Lipids; Lysophosphatidylcholines; Male; Matrix Metalloproteinase 1; Mice; Mice, Inbred BALB C; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor-alpha | 2009 |
Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.
Topics: Amitriptyline; Animals; Bile Ducts; Biomarkers; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; Clomipramine; Discriminant Analysis; Disease Models, Animal; Glucosylceramides; Hepatocytes; Imipramine; Least-Squares Analysis; Liver; Lysophosphatidylcholines; Lysosomal Storage Diseases; Male; Mass Spectrometry; Metabolomics; Multivariate Analysis; Predictive Value of Tests; Rats | 2014 |